Observational study / 2018
In super-obese patients, intragastric balloon alone was linked to modest 60-month weight loss, whereas balloon followed by bariatric surgery showed greater reductions.
Between 2000 and 2016, 207 super-obese patients had an ORBERA intragastric balloon placed, either alone with lifestyle therapy (n=76) or followed by definitive bariatric surgery (n=131). At 60 months, the balloon alone with lifestyle changes group demonstrated an excess weight loss of 9.04% and a BMI drop of 3.8. Balloon with gastric banding demonstrated an excess weight loss of 32.9% and BMI drop of 8.9, while balloon with a definitive stapled procedure demonstrated a BMI drop of 17.6 and an excess weight loss of 52.8%. Overall, 3 deaths (1.4%) occurred: 2 within 10 days due to acute gastric perforation secondary to vomiting and 1 cardiac arrest at 4 weeks postoperatively.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 207 super-obese patients (mean BMI 57.3 kg/m2, mean age 44.5 years)
- What was measured
- Body mass index (BMI) drop and excess weight loss over up to 60 months, plus adverse events
THE PAPER
Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series.
Ashrafian H, Monnich M, Braby TS, Smellie J, Bonanomi G, Efthimiou E. Surg Obes Relat Dis, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.